Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.

Saved in:
Bibliographic Details
Title: Biomarker testing implementation for molecularly targeted therapy in non-small cell lung cancer patients.
Authors: Lorenzini D; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy., Gaudioso G; Division of Clinical Pathology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy., Scardoni A; Welfare General Directorate, Regione Lombardia, Milan, Italy., Blandi L; Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Lombardia, Italy., Del Gobbo A; Division of Pathology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy., Rafaniello Raviele P; Division of Pathology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy., Ferrero S; Division of Pathology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.; Department of Medical, Surgical and Dental Sciences, University of Milan, Milan, Italy., Veronese SM; Division of Pathology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Lauricella C; Division of Pathology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy., Pagni F; Department of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, Università di Milano-Bicocca, Monza, Italy., Seminati D; Department of Medicine and Surgery, Pathology, Fondazione IRCCS San Gerardo dei Tintori, Università di Milano-Bicocca, Monza, Italy., Miozzo M; Medical Genetics Unit, Department of Health Science, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy., Pesenti C; Medical Genetics Unit, Department of Health Science, ASST Santi Paolo e Carlo, University of Milan, Milan, Italy., Gianelli U; Unit of Human Pathology, Department of Health Sciences Santi Paolo e Carlo Medical School, University of Milan, Milan, Italy., Buiatiotis S; Unit of Human Pathology, Department of Health Sciences Santi Paolo e Carlo Medical School, University of Milan, Milan, Italy., Fumagalli C; Unit of Human Pathology, Department of Health Sciences Santi Paolo e Carlo Medical School, University of Milan, Milan, Italy., Guerini Rocco E; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Rappa A; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Barberis M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Fusco N; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Ranghiero A; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., La Rosa S; Unit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy., Sessa F; Unit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy., Furlan D; Unit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy., Sahnane N; Unit of Pathology, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy., Patriarca C; Pathology Unit, St. Anna Hospital (ASST Lariana), Como, Italy., Cangi MG; Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Lume A; Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Doglioni C; Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Ponzoni M; Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Vermi W; Department of Molecular and Translational Medicine, University of Brescia, ASST Spedali Civili, Brescia, Italy., Novali M; Respiratory Department, Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Lombardia, Italy., Paulli M; Pathology Unit, Fondazione IRCCS Policlinico 'San Matteo', Pavia, Italy.; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Boveri E; Pathology Unit, Fondazione IRCCS Policlinico 'San Matteo', Pavia, Italy., Terracciano L; Department of Pathology, IRCSS Humanitas Research Hospital, Rozzano-Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Uccella S; Department of Pathology, IRCSS Humanitas Research Hospital, Rozzano-Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Destro A; Department of Pathology, IRCSS Humanitas Research Hospital, Rozzano-Milan, Italy., Tamborini E; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Perrone F; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Pasotti F; Directorate General for Health, Lombardy Region, Milan, Italy., Agustoni F; Medical Oncology Department, Fondazione IRCCS Policlinico 'San Matteo', Pavia, Italy., De Braud F; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Grossi F; Division of Medical Oncology, Department of Medicine and Technological Innovation, University of Insubria, Varese, Italy., Siena S; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Curigliano G; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Buoro S; Directorate General for Health, Lombardy Region, Milan, Italy., Pruneri G; Department of Diagnostic Innovation, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy.; Department of Oncology and Hematology-Oncology, University of Milan, Milan, Italy.
Source: Tumori [Tumori] 2025 Aug; Vol. 111 (4), pp. 293-301. Date of Electronic Publication: 2025 Jul 10.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Sage Publications Country of Publication: United States NLM ID: 0111356 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2038-2529 (Electronic) Linking ISSN: 03008916 NLM ISO Abbreviation: Tumori Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2038-2529
DOI:10.1177/03008916251341996